1-4 of 4
Robert A. Kirken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK + anaplastic large-cell lymphoma cells

Lin Qiu, Raymond Lai, Quan Lin, Esther Lau, David M. Thomazy, Daniel Calame, Richard J. Ford, Larry W. Kwak, Robert A. Kirken, Hesham M. Amin
Journal: Blood
Blood (2006) 108 (7): 2407–2415.
https://doi.org/10.1182/blood-2006-04-020305
Published: 2006
Journal Articles

Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin

Stanislaw M. Stepkowski, Rebecca A. Erwin-Cohen, Fariba Behbod, Mou-Er Wang, Xienui Qu, Neelam Tejpal, Zsuzsanna S. Nagy, Barry D. Kahan, Robert A. Kirken
Journal: Blood
Blood (2002) 99 (2): 680–689.
https://doi.org/10.1182/blood.V99.2.680
Published: 2002
Journal Articles

Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells

Li Hua Wang, Robert A. Kirken, Xiao Yi Yang, Rebecca A. Erwin, Luis DaSilva, Cheng-Rong Yu, William L. Farrar
Journal: Blood
Blood (2000) 95 (12): 3816–3822.
https://doi.org/10.1182/blood.V95.12.3816
Published: 2000
Journal Articles

Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4–driven T H 2 cell response

Li Hua Wang, Xiao Yi Yang, Robert A. Kirken, James H. Resau, William L. Farrar
Journal: Blood
Blood (2000) 95 (4): 1249–1257.
https://doi.org/10.1182/blood.V95.4.1249.004k39_1249_1257
Published: 2000